Four novel <em>ARSA</em> gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations-Reference-Cited by-同舟云学术

Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutations

Published:2017-06 Issue: Volume:Volume 13 Page:725-731
ISSN:1178-203X
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:TCRM

Author:

Dehghan Manshadi Masoumeh,Kamalidehghan Behnam,Aryani Omid,Khalili Elham,Dadgar Sepideh,Tondar Mahdi,Ahmadipour Fatemeh,Yong Meng Goh,Houshmand Massoud

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy;International Journal of Biological Macromolecules;2024-02

2. Exploring the effect of disease causing mutations in metal binding sites of human ARSA in metachromatic leukodystrophy;Advances in Protein Chemistry and Structural Biology;2024

3. Predicting disease severity in metachromatic leukodystrophy using protein activity and a patient phenotype matrix;Genome Biology;2023-07-21

4. Current Understanding on the Genetic Basis of Key Metabolic Disorders: A Review;Biology;2022-09-02

5. Clinical, Biochemical, and Molecular Characterization of Metachromatic Leukodystrophy Among Egyptian Pediatric Patients: Expansion of the ARSA Mutational Spectrum;Journal of Molecular Neuroscience;2020-11-13